期刊文献+

含L-酪氨酸结构的五环三萜衍生物的合成及糖原磷酸化酶抑制活性研究 被引量:2

Synthesis of Pentacyclic Triterpenes Bearing L-tyrosine and Their Inhibitory Activity against Glycogen Phosphorylase
下载PDF
导出
摘要 目的提高五环三萜化合物的活性,改善其水溶性。方法以五环三萜化合物积雪草酸、甘草次酸为原料,分别经过烷基化、水解等反应,在其羧基位引入L-酪氨酸结构片段。结果合成了4个含L-酪氨酸结构的五环三萜衍生物,并对所有目标化合物进行了糖原磷酸化酶抑制活性测试。结论甘草次酸的衍生物表现出了一定的糖原磷酸化酶抑制活性,其中化合物7(IC50=8.38μmol/L)抑制活性优异,超过其先导化合物甘草次酸(IC50=66μmol/L)。 Objective To enhance the activity and improve the water solubility of pentacyclic triterpenes. Methods The novel derivatives were synthesized by alkylation and hydrolysis reactions from asiatic acid and glycyrrhetic acid at whose carboxyl group the L-tyrosine fragment was introduced. Results Four novel derivatives bearing L-tyrosine fragment were synthesized and their inhibitory activities against glycogen phosphorylase (GP) were detected. Conclusion The derivatives of glycyrrhetic acid exhibited particular inhibitory activities against glycogen phosphorylase. Among them, compound 7 showed excellent inhibitive activity with IC50 of 8.38 μmol/L, which exceeded the IC50 of glycyrrhetic acid of 66 μmol/L.
出处 《食品与药品》 CAS 2016年第3期156-160,共5页 Food and Drug
基金 河北省教育厅资助项目(No.Y2012026)
关键词 五环三萜 积雪草酸 甘草次酸 糖原磷酸化酶抑制剂 pentacyclic triterpene asiatic acid glycyrrhetic acid glycogen phosphorylase inhibitor
  • 相关文献

参考文献8

  • 1刘伟.新诊糖尿病患者的评估和检查[J].糖尿病天地(临床),2015,9(6):299-302. 被引量:1
  • 2张娟,熊玉卿.五环三萜类化合物吸收特征的研究进展[J].中草药,2009,40(9):1505-1508. 被引量:5
  • 3Wen X, Sun H, Liu J, et al. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies[J]. JMed Chem, 2008, 51(12): 3540-3554.
  • 4Peters J M, Shah Y M, Gonzalez F J. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention[J]. Nat Rev Cancer, 2012, 12(3): 181-195.
  • 5Yuan H, Upadhyay G, Yin Y, et al. Stem cell Antigen-1 deficiency enhances the chemopreventive effect of peroxisome proliferator- activated receptor), activation [J]. Cancer Prev Res, 2012, 5(1): 51-60.
  • 6Ma Y, Wang S, Xu W, et al. Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach [J]. PLoS One, 2012, 7(6): e38546.
  • 7蔡哲峰,郭宗儒.PPARγ调节剂研究进展[J].药学学报,2004,39(2):158-160. 被引量:14
  • 8Martin W, Hoover D, Armento S J, et al. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo[J]. Proc NatlAcadSci, 1998, 95(4): 1776-1781.

二级参考文献32

  • 1王胜春,赵辉平,皇甫孟君.五灵胶囊中柴胡皂苷d在小鼠体内药代动力学研究[J].中成药,2005,27(7):809-811. 被引量:13
  • 2程晓华,熊玉卿.五环三萜皂苷的药理作用研究进展[J].中草药,2007,38(5):792-795. 被引量:59
  • 3郭歆,曹伟,程泽能,黄志壮,李焕德.齐墩果酸大鼠肠吸收动力学[J].中南药学,2007,5(3):216-219. 被引量:17
  • 4陈晓燕,狄留庆,赵晓莉,单进军,杨玲娟,朱蓉蓉,钱桂英.通塞脉微丸活性成分的大鼠在体肠吸收研究[J].南京中医药大学学报,2007,23(4):231-233. 被引量:3
  • 5Ohta K Y, Inoue K, Hayashi Y, et al. Carried-mediated transport of glycerol in the perfused rat small intestine [J]. Biol Pharm Bull, 2006, 29(4): 785-789.
  • 6Balimane P V, Chong S. Cell culture-based models for intestinal permeability: acritique [J]. Drug Discov Today, 2005, 10(5) : 335-343.
  • 7He Y, Zeng S. Determination of the stereoselectivity of chiral drug transport across Caco-2 cell monolayers [J]. Chirality, 2006, 18(1): 64-69.
  • 8van Breemen R B, Li Y. Caco-2 cell permeability assays to measure drug absorption [J].Expert Opin Drug Metab Toxico, 2005, 1(2): 175-185.
  • 9Seeling A, Gerebtzoff G. Enhancement of drug absorption by noneharged detergents through membrane and P-glycoprotein binding [J]. ExpertOpin Drug Metab To:cicol, 2006, 2(5) : 733-752.
  • 10Imai T, Sakai M, Ohtake H, et al. Absorption-enhancing effect of glyeyrrhizin induced in the presence of capric acid [J]. IntJ Pharm, 2005, 294: 11-21.

共引文献17

同被引文献27

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部